ESLA
Estrella Immunopharma Inc.
0.6393$
-12.3%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Estrella Immunopharma Inc. (ESLA) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/29/2026 | Current report (8-K) | Estrella Immunopharma, Inc. (ESLA): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/08/2026 | Current report (8-K) | Estrella Immunopharma, Inc. (ESLA): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | View report ↗ |
| 08/21/2026 | Current report (8-K) | Estrella Immunopharma, Inc. (ESLA): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.